Pursuant to Regulations 29 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Pharmaids Pharmaceuticals has informed that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday, 04th August 2023 to consider and approve the unaudited financial results for the quarter and three months ended 30th June 2023 along with Limited Review Report given by the Statutory Auditors. Further, in accordance with its letter dated 30th June 2023 the Trading Window for dealing in securities of the Company by the Designated Person and their immediate relatives shall remain closed till 48 hours after communication of aforesaid Financial Results to the Stock Exchange.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: